Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms

Tang, Yanan; Jiang, Dingding; Wang, Xuejun; Liu, Yunqi; Wei, Dacheng

doi:10.1016/j.cclet.2023.108688

Cited by 10 publications

(8 citation statements)

References 151 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent research progress in POC testing-based methods for detecting SARS-CoV-2 includes comparisons of nucleic acid tests, immunoassays, and novel sensors. 372 Emerging sensor detection technologies, such SPR and electrochemical methods, offer rapid detection capabilities and low detection limits. However, selectivity restrictions, sample pretreatment, and preparation costs suggest the potential for further advancement.…”

Section: Perspectives On Healthcare Management Of Futuristic Infectio...mentioning

confidence: 99%

Engineered two-dimensional nanomaterials based diagnostics integrated with internet of medical things (IoMT) for COVID-19

Sadique,

Yadav,

Khan

et al. 2024

Chem. Soc. Rev.

View full text Add to dashboard Cite

show abstract

Section: Perspectives On Healthcare Management Of Futuristic Infectio...mentioning

confidence: 99%

Engineered two-dimensional nanomaterials based diagnostics integrated with internet of medical things (IoMT) for COVID-19

Sadique,

Yadav,

Khan

et al. 2024

Chem. Soc. Rev.

View full text Add to dashboard Cite

show abstract

“…NEAR is a novel automated technique with a very promising value for POC [ 43 , 50 ]. NEAR can achieve a linear amplification of a DNA template using two enzymes (nicking endonuclease and DNA polymerase) [ 158 , 159 ]. Polymerase activity was noted for improved sensitivity and efficiency in the past [ 49 ].…”

Section: Overview Of Rapid Testing Optionsmentioning

confidence: 99%

The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania

Drevinek,

Flisiak,

Nemes

et al. 2024

Diagnostics

View full text Add to dashboard Cite

This review aims to explore the role of professional diagnostic rapid testing of acute respiratory infections (ARIs), especially COVID-19 and influenza, ensuring proper disease management and treatment in Europe, and particularly in Czech Republic, Poland, and Romania. The paper was constructed based on a review of scientific evidence and national and international policies and recommendations, as well as a process of validation by four experts. The development of new testing technologies, treatment options, and increased awareness of the negative multidimensional impact of ARI profiles transformed differential diagnosis into a tangible and desirable reality. This review covers the following topics: (1) the multidimensional impact of ARIs, (2) ARI rapid diagnostic testing platforms and their value, (3) the policy landscape, (4) challenges and barriers to implementation, and (5) a set of recommendations illustrating a path forward. The findings indicate that rapid diagnostic testing, including at the point of care (POC), can have a positive impact on case management, antimicrobial and antibiotic stewardship, epidemiological surveillance, and decision making. Integrating this strategy will require the commitment of governments and the international and academic communities, especially as we identified room for improvement in the access and expansion of POC rapid testing in the focus countries and the inclusion of rapid testing in relevant policies.

show abstract

“…NEAR has at least three main advantages: the potential for high sensitivity, easy application, and clinically relevant turnaround time. NEAR uses two enzymes, nicking endonuclease and DNA polymerase, for DNA amplification [156,157], with the second having shown improved sensitivity in the past [158]. Since NEAR tests can take place inside the manufacturer's instrument, they are easy for non-laboratory staff to use, requiring only the instrument and a cartridge to be applied [146].…”

Section: Types Of Tests Available For Detecting Covid-19mentioning

confidence: 99%

Differential Diagnosis in the Management of Acute Respiratory Infections through Point-of-Care Rapid Testing in a Post-Pandemic Scenario in Latin America: Special Focus on COVID-19, Influenza, and Respiratory Syncytial Virus

Alvarez-Moreno,

de Araújo,

Baumeister

et al. 2024

COVID

View full text Add to dashboard Cite

This review provides a comprehensive summary of evidence to explore the role and value of differential diagnosis in the management of Acute Respiratory Infections (ARIs) through point-of-care (POC) rapid testing in a post-pandemic scenario, paying particular attention to coronavirus disease 2019 (COVID-19), influenza, and respiratory syncytial virus (RSV). The document builds on a review of literature and policies and a process of validation and feedback by a group of seven experts from Latin America (LATAM). Evidence was collected to understand scientific and policy perspectives on the differential diagnosis of ARIs and POC rapid testing, with a focus on seven countries: Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru. The evidence indicates that POC rapid testing can serve to improve ARI case management, epidemiological surveillance, research and innovation, and evidence-based decision-making. With multiple types of rapid tests available for POC, decisions regarding which tests to use require the consideration of the testing purpose, available resources, and test characteristics regarding accuracy, accessibility, affordability, and results turnaround time. Based on the understanding of the current situation, this document provides a set of recommendations for the implementation of POC rapid testing in LATAM, supporting decision-making and guiding efforts by a broad range of stakeholders.

show abstract

Recent progress on rapid diagnosis of COVID-19 by point-of-care testing platforms

Cited by 10 publications

References 151 publications

Engineered two-dimensional nanomaterials based diagnostics integrated with internet of medical things (IoMT) for COVID-19

Engineered two-dimensional nanomaterials based diagnostics integrated with internet of medical things (IoMT) for COVID-19

The Role and Value of Professional Rapid Testing of Acute Respiratory Infections (ARIs) in Europe: A Special Focus on the Czech Republic, Poland, and Romania

Differential Diagnosis in the Management of Acute Respiratory Infections through Point-of-Care Rapid Testing in a Post-Pandemic Scenario in Latin America: Special Focus on COVID-19, Influenza, and Respiratory Syncytial Virus

Contact Info

Product

Resources

About